Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.
暂无分享,去创建一个
Barbara L. Smith | A. Niemierko | J. Bellon | Jay R. Harris | A. Taghian | P. Nguyen | N. Arvold | R. A. Abi Raad | Meera Sreedhara | J. Wong | Nils D. Arvold | J. Harris | P. Nguyen
[1] X. Chen,et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.
[2] R. Gelber,et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] Charles M Perou,et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] A. Luini,et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] T. Nielsen,et al. Breast cancer subtypes and the risk of local and regional relapse. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] D. Hicks,et al. Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis: Are We Ready? , 2009, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[7] J. Costantino,et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Charles M. Perou,et al. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.
[9] J. Marks,et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] S. Edge,et al. American College of Radiology appropriateness criteria on conservative surgery and radiation: stages I and II breast carcinoma. , 2008, Journal of the American College of Radiology : JACR.
[11] Barbara L. Smith,et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] M. Keyes,et al. Is mastectomy superior to breast-conserving treatment for young women? , 2007, International journal of radiation oncology, biology, physics.
[13] A. Vincent-Salomon,et al. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[15] Zhiyuan Hu,et al. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[17] M. Dowsett,et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. , 2005, The New England journal of medicine.
[18] Greg Yothers,et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.
[19] Roman Rouzier,et al. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.
[20] S. Singletary,et al. Improving local control with breast‐conserving therapy , 2005, Cancer.
[21] N. Klauber-DeMore. Tumor biology of breast cancer in young women. , 2005, Breast disease.
[22] F. Vicini,et al. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast‐conserving therapy at a single institution , 2004, Cancer.
[23] U. W. Jayasinghe,et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node‐negative breast carcinoma , 2004, Cancer.
[24] H. Mouridsen,et al. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. , 2004, Cancer.
[25] W. Han,et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer , 2004, BMC Cancer.
[26] F. Ong,et al. The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. , 2003, International journal of radiation oncology, biology, physics.
[27] L Collette,et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? , 2003, European journal of cancer.
[28] U. W. Jayasinghe,et al. The effect of margins on ipsilateral breast tumour recurrence after breast, conservation therapy for node-negative breast cancer. , 2002 .
[29] Umberto Veronesi,et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.
[30] B. E. F. Isher,et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .
[31] Norman Wolmark,et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] F. Spyratos,et al. Correlation between MIB‐1 and other proliferation markers , 2002, Cancer.
[33] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Bryant,et al. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. , 2001, Journal of the National Cancer Institute.
[35] G. Hortobagyi,et al. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] J. Peterse,et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] E van der Schueren,et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2001, Journal of the National Cancer Institute.
[38] J. Boyages,et al. Three-dimensional dose distribution of tangential breast irradiation: results of a multicentre phantom dosimetry study. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[39] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[40] P. Andersen,et al. Factors influencing the effect of age on prognosis in breast cancer: population based study , 2000, BMJ : British Medical Journal.
[41] M. J. van de Vijver,et al. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. , 1998, International journal of radiation oncology, biology, physics.
[42] I J Das,et al. Dosimetric comparison of treatment planning systems in irradiation of breast with tangential fields. , 1997, International journal of radiation oncology, biology, physics.
[43] P Okunieff,et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. , 1995, The New England journal of medicine.
[44] D. Schultz,et al. The influence of young age on outcome in early stage breast cancer. , 1994, International journal of radiation oncology, biology, physics.
[45] D. Neuberg,et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] B. McCormick. Selection criteria for breast conservation: The impact of young and old age and collagen vascular disease , 1994, Cancer.
[47] D. Allred,et al. Breast cancer outcome and predictors of outcome: are there age differentials? , 1994, Journal of the National Cancer Institute. Monographs.
[48] G. Swanson,et al. Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment. , 1994, Journal of the National Cancer Institute. Monographs.
[49] C. Redmond,et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. , 1992, Seminars in surgical oncology.
[50] H. Bartelink,et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. , 1992, European journal of cancer.
[51] H. Mouridsen,et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. , 1992, Journal of the National Cancer Institute. Monographs.
[52] D. Schultz,et al. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. , 1991, International journal of radiation oncology, biology, physics.
[53] H. Kooy,et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[54] C. Bressac,et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] F. Ames,et al. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer , 1989, Cancer.
[56] B Fisher,et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.
[57] C. Redmond,et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. , 1989, The New England journal of medicine.
[58] D. Schultz,et al. Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer. , 1987, International journal of radiation oncology, biology, physics.
[59] S. Schnitt,et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. , 1988, International journal of radiation oncology, biology, physics.
[60] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[61] T. Mate,et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma , 1986, Cancer.
[62] B Fisher,et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.
[63] R. Arriagada,et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. , 1984, International journal of radiation oncology, biology, physics.